Bildkälla: Stockfoto

InDex Pharmaceuticals: Business Update - Redeye

Watch the replay from InDex Pharmaceuticals' business update on May 9. The event featured the company's leadership team sharing insights and updates on the ongoing phase 3 CONCLUDE clinical program with the company's lead asset, cobitolimod. The event also featured a Q&A, among other things.

Watch the replay from InDex Pharmaceuticals' business update on May 9. The event featured the company's leadership team sharing insights and updates on the ongoing phase 3 CONCLUDE clinical program with the company's lead asset, cobitolimod. The event also featured a Q&A, among other things.
Börsvärldens nyhetsbrev
ANNONSER